Comment
doi: 10.1136/bmj.39202.397488.AD.
Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? No
Affiliations
- PMID: 17494018
- PMCID: PMC1867901
- DOI: 10.1136/bmj.39202.397488.AD
Item in Clipboard
Comment
Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? No
BMJ.
.
Abstract
Women in western countries are more likely to die from heart disease than from cancer. Scott M Grundy argues that the risks make preventive treatment essential, but Malcolm Kendrick believes the evidence of benefit is not strong enough
Conflict of interest statement
Comment on
-
Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? Yes.BMJ. 2007 May 12;334(7601):982. doi: 10.1136/bmj.39202.399942.AD. BMJ. 2007. PMID: 17494017 Free PMC article.
Similar articles
-
Integrating economic analysis into clinical trials.Lancet. 2005 May 21-27;365(9473):1749-50. doi: 10.1016/S0140-6736(05)66390-8. Lancet. 2005. PMID: 15910936 No abstract available.
-
[How far the rates of cholesterol have to be lowered in primary prevention?].Rev Med Suisse. 2010 Mar 10;6(239):483-4. Rev Med Suisse. 2010. PMID: 20373693 French. No abstract available.
-
[2008 National Cardiology Guidelines: Prioritization requires consideration to other factors than scientific studies alone].Lakartidningen. 2008 May 7-13;105(19):1408-9; discussion 1409. Lakartidningen. 2008. PMID: 18574983 Swedish. No abstract available.
-
Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.Expert Rev Cardiovasc Ther. 2006 May;4(3):345-51. doi: 10.1586/14779072.4.3.345. Expert Rev Cardiovasc Ther. 2006. PMID: 16716095 Review.
-
Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal.Arch Intern Med. 2010 Jun 28;170(12):1032-6. doi: 10.1001/archinternmed.2010.184. Arch Intern Med. 2010. PMID: 20585068 Review.
Cited by
-
Sex differences in cardiologic medication provision for adults with coronary heart disease: an analysis of health claims data from 2018 to 2020 in Saxony-Anhalt, Germany.BMC Health Serv Res. 2024 Mar 6;24(1):288. doi: 10.1186/s12913-024-10727-4. BMC Health Serv Res. 2024. PMID: 38448928 Free PMC article.
-
Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22.Circ Cardiovasc Qual Outcomes. 2011 May;4(3):328-36. doi: 10.1161/CIRCOUTCOMES.110.957720. Epub 2011 Apr 12. Circ Cardiovasc Qual Outcomes. 2011. PMID: 21487089 Free PMC article. Clinical Trial.
-
Cardiovascular disease and primary ovarian insufficiency.Semin Reprod Med. 2011 Jul;29(4):328-41. doi: 10.1055/s-0031-1280918. Epub 2011 Oct 3. Semin Reprod Med. 2011. PMID: 21969267 Free PMC article. Review.
-
Response by sex to statin plus ezetimibe or statin monotherapy: a pooled analysis of 22,231 hyperlipidemic patients.Lipids Health Dis. 2011 Aug 22;10:146. doi: 10.1186/1476-511X-10-146. Lipids Health Dis. 2011. PMID: 21859459 Free PMC article.
-
Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials.Circulation. 2010 Mar 9;121(9):1069-77. doi: 10.1161/CIRCULATIONAHA.109.906479. Epub 2010 Feb 22. Circulation. 2010. PMID: 20176986 Free PMC article. Clinical Trial.
References
-
- Miettinen TA, Pyorala K, Olsson AG, Musliner TA, Cook TJ, Faergeman O, et al. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian simvastatin survival study (4S). Circulation 1997;96:4124-5. - PubMed
-
- Walsh JM, Pignone M. Drug treatment of hyperlipidemia in women. JAMA 2004;291:2243-52. - PubMed
-
- Draeger A, Monastyrskaya K, Mohaupt M, Hoppeler H, Savolainen H, Allemann C. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia. J Pathol 2006;210:94-102. - PubMed
-
- Stepper HD. Letter in response (F04-172). Rockville, MD: Public Health Service Center for Drug Evaluation and Research Office of Regulatory Policy, Division of Information Disclosure Policy, 2004.
-
- Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet 1994;334:1383-9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
